1                                              Eflornithine, alone or combined with nifurtimox, is bein

2 T. brucei, thereby decreasing sensitivity to eflornithine and increasing sensitivity to suramin.

3                              The addition of eflornithine caused no change in the accumulation of nif

4 t the BBB, but also the impact of nifurtimox-eflornithine combination therapy (NECT) and other anti-H

5         The recent development of nifurtimox-eflornithine combination therapy (NECT) has brought new

6  Health Organization approved the nifurtimox-eflornithine combination therapy for the treatment of hu

7                                              Eflornithine combined with nifurtimox is the first-line

8 ornithine decarboxylase (ODC) using low-dose eflornithine (DFMO, CPP-1X), combined with maximal PA ex

9                      The "resurrection drug" eflornithine (difluoromethylornithine), which is used cl

10 : difluoromethylornithine (DFMO; also called eflornithine), which is a suicide inhibitor of ornithine

11 s the target of the WHO "essential medicine" eflornithine, which is antagonistic to another anti-HAT